BIOVANTIC PHARMA MEDICAL DEVICES LIMITED
Biovantic Pharma
Biovantic Pharma is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. Biovantic Pharma product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars, brands and OTC products.
- Type
- Manufacturer
- Location
- United Kingdom
- Website
- https://biovanticpharma.co.uk
- Categories
- Pharmaceutical Manufacturing, Medical & Healthcare Supplies
Listed in a source registry
Verified facts
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
- places-goods-on-market (green), checked 2026-08-16 Registre national des producteurs (ADEME/SYDEREP), France
- registry-id-verified (green), checked 2026-08-02 Companies House
- directors-on-file (green), checked 2026-08-15 Companies House register of persons with significant control (UK)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)